Toxic epidermal necrolysis: differential diagnosis of an epidermolytic dermopathy in a hematopoietic stem cell transplant recipient
- 1 September 2002
- journal article
- case report
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 30 (5), 331-333
- https://doi.org/10.1038/sj.bmt.1703624
Abstract
Toxic epidermal necrolysis (TEN) is an epidermolytic skin disorder associated with drug administration. It is associated with an erythematous rash with full thickness epidermal loss and characteristic histology. A 35-year-old woman underwent allogeneic hematopoietic stem cell transplantation (HSCT) for severe aplastic anemia (SAA). She developed an acute epidermolytic rash and TEN was diagnosed on the basis of skin biopsy. In the HSCT setting, TEN should be thought of as an important differential diagnosis of epidermolytic dermopathies. The most distinctive diagnostic test in the differential diagnosis of these disorders is skin biopsyKeywords
This publication has 11 references indexed in Scilit:
- Management of toxic epidermal necrolysisHospital Medicine, 2000
- Treatment of Severe Drug EruptionsThe Journal of Dermatology, 1999
- Advances in toxic epidermal necrolysisSeminars in Cutaneous Medicine and Surgery, 1996
- Epidemiology of drug-induced severe skin reactionsSeminars in Cutaneous Medicine and Surgery, 1996
- Toxic epidermal necrolysis: A reviewJournal of the American Academy of Dermatology, 1991
- Toxic epidermal necrolysis (Lyell syndrome)Journal of the American Academy of Dermatology, 1990
- Toxic epidermal necrolysis after bone marrow transplantation: Study of nine casesJournal of the American Academy of Dermatology, 1990
- Toxic Epidermal NecrolysisArchives of Dermatology, 1987
- Acute epidermal necrolysis of Lyell syndromeEuropean Journal of Pediatrics, 1987
- Cutaneous drug reactions: Pathogenesis and clinical classificationJournal of the American Academy of Dermatology, 1985